AbbVie (ABBV) Increases Buyback by $5B

The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program.

Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.

You May Also Be Interested In

• Wolfe Research Upgrades Abbvie (ABBV) to Outperform
• Cable One names Heather McCallion as chief operating officer
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation